![](/img/cover-not-exists.png)
Phase II study of oral topotecan (T) with cisplatin (C) in advanced, non-resectable NSCLC. A promising combination
Palshof, T, Rivière, A, Moreau, L, Breton, J.L, Hearn, S, Fields, S.Z, Ross, GVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80115-4
Date:
September, 2000
File:
PDF, 105 KB
english, 2000